SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:lup.lub.lu.se:d5a45b94-1916-4370-80fa-c54e96a80af7"
 

Sökning: onr:"swepub:oai:lup.lub.lu.se:d5a45b94-1916-4370-80fa-c54e96a80af7" > Resource utilisatio...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004175naa a2200601 4500
001oai:lup.lub.lu.se:d5a45b94-1916-4370-80fa-c54e96a80af7
003SwePub
008160401s2008 | |||||||||||000 ||eng|
024a https://lup.lub.lu.se/record/12472652 URI
024a https://doi.org/10.1007/s00125-008-1089-62 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
100a Prompers, L.4 aut
2451 0a Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study
264 c 2008-07-22
264 1b Springer Science and Business Media LLC,c 2008
520 a Aims/hypothesis The aim of the present study was to investigate resource utilisation and associated costs in patients with diabetic foot ulcers and to analyse differences in resource utilisation between individuals with or without peripheral arterial disease (PAD) and/or infection. Methods Data on resource utilisation were collected prospectively in a European multicentre study. Data on 1,088 patients were available for the analysis of resource use, and data on 821 patients were included in the costing analysis. Costs were calculated for each patient by multiplying the country-specific direct and indirect unit costs by the number of resources used from inclusion into the study up to a defined endpoint. Country-specific costs were converted into purchasing power standards. Results Resource use and costs varied between outcome groups and between disease severity groups. The highest costs per patient were for hospitalisation, antibiotics, amputations and other surgery. All types of resource utilisation and costs increased with the severity of disease. The total cost per patient was more than four times higher for patients with infection and PAD at inclusion than for patients in the least severe group, who had neither. Conclusions/interpretation Important differences in resource use and costs were found between different patient groups. The costs are highest for individuals with both peripheral arterial disease and infection, and these are mainly related to substantial costs for hospitalisation. In view of the magnitude of the costs associated with in-hospital stay, reducing the number and duration of hospital admissions seems an attractive option to decrease costs in diabetic foot disease.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng
653 a prospective
653 a multicentre
653 a foot ulcer
653 a European
653 a costs
653 a diabetes
653 a resource utilisation
700a Huijberts, M.4 aut
700a Schaper, N.4 aut
700a Apelqvist, Janu Lund University,Lunds universitet,Genomik, diabetes och endokrinologi,Forskargrupper vid Lunds universitet,Genomics, Diabetes and Endocrinology,Lund University Research Groups4 aut0 (Swepub:lu)endo-jap
700a Bakker, K.4 aut
700a Edmonds, M.4 aut
700a Holstein, P.4 aut
700a Jude, E.4 aut
700a Jirkovska, A.4 aut
700a Mauricio, D.4 aut
700a Piaggesi, A.4 aut
700a Reike, H.4 aut
700a Spraul, M.4 aut
700a Van Acker, K.4 aut
700a Van Baal, S.4 aut
700a Van Merode, F.4 aut
700a Uccioli, L.4 aut
700a Urbancic, V.4 aut
700a Tennvall, G. Ragnarson4 aut
710a Genomik, diabetes och endokrinologib Forskargrupper vid Lunds universitet4 org
773t Diabetologiad : Springer Science and Business Media LLCg 51:10, s. 1826-1834q 51:10<1826-1834x 1432-0428x 0012-186X
856u http://dx.doi.org/10.1007/s00125-008-1089-6y FULLTEXT
856u https://link.springer.com/content/pdf/10.1007%2Fs00125-008-1089-6.pdf
8564 8u https://lup.lub.lu.se/record/1247265
8564 8u https://doi.org/10.1007/s00125-008-1089-6

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy